Navigation Links
Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
Date:6/29/2009

SHANGHAI, June 29 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr. Tong Xu has been appointed Vice President of Process Chemistry Services.

Prior to joining Sundia, Dr. Xu worked at La Jolla Pharmaceutical Company, an R&D based biotech company in San Diego, USA for 12 years. At La Jolla Pharmaceutical Company, Dr. Xu rose through the ranks from Research Scientist, to Manager, Senior Manager, and Associate Director of Process Development. Through this career path, he accumulated extensive experience in developing and managing process chemistry programs. His accomplishments include directing process development effort of Riquent(R) at clinical phase III and pre-commercialization stage.

"I am very pleased to welcome Dr. Xu to join Sundia. He is not only an outstanding scientist and research fellow, but also an experienced business manager," said Dr. Xiaochuan Wang, Chairman and CEO of Sundia. "Dr. Xu led the effort in his previous employment to search, select, negotiate and qualify CRO service providers in GLP and cGMP production of raw materials, starting materials, and API intermediates. This experience is very valuable for his new role to lead process chemistry CRO services at Sundia."

Dr. Xu received his bachelor's degree in Chemistry from Nankai University, and his Ph.D. degree in Organic Chemistry from the University of Michigan in USA. He also obtained an MBA with focus on finance and entrepreneurship from the Anderson School of Management at UCLA in USA.

About Sundia: Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China, to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from early hit screening, biological service, lead optimization, DMPK, candidate preclinical development, formulation development, API manufacture, and regulatory submission. For more information, please visit http://www.sundia.com .


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
2. Sundias Animal Facility Passed Client and Government Inspection
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
5. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
6. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
7. Novavax Appoints Stanley Erck to Board of Directors
8. Qforma Appoints Four Executives in Sales and Field Operations
9. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
10. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
11. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , ... April 18, 2017 , ... A number of ... This webinar, which is part of the Protein and Cell Analysis Education Webinar ... outline where this technology fits in current and future applications. , Many flow ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark ... Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, ... trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... to novices as well as experienced users, attendees will gain a better understanding ... tests. , Hemostasis testing quality is determined by preanalytical variables which encompass ...
(Date:4/19/2017)... and WESTMINSTER, Colo. ... LLC ("Oxford"), an industry-leading specialty finance firm that ... services companies, today announced the closing of a ... Inc. ("Cerapedics") a privately-held orthobiologics company engaged in ... products for the treatment of orthopedic injuries. ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):